Skip to main content
Livermore
Livermore
ZHEN

TCG Crossover Management, LLC

SEC CIK
0001839948
Latest filing
Aug 14, 2026

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overviewAll 13F holders of DYNFull Q2 2026 holdings

Shares (Q2 2026)
4,615,144
Value
$102.5M
% of portfolio
2.5%
Quarters held
14
Since Q1 2023
Holdings of DYN by TCG Crossover Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,615,144$102.5M2.5%00.0%UnchangedHolders
Q1 20264,615,144$83.7M2.4%00.0%UnchangedHolders
Q4 20254,615,144$90.3M3.0%00.0%UnchangedHolders
Q3 20254,615,144$58.4M2.9%+848,484+22.5%AddedHolders
Q2 20253,766,660$35.9M4.1%+1,116,510+42.1%AddedHolders
Q1 20252,650,150$27.7M3.8%00.0%UnchangedHolders
Q4 20242,650,150$62.4M6.1%00.0%UnchangedHolders
Q3 20242,650,150$95.2M8.1%00.0%UnchangedHolders
Q2 20242,650,150$93.5M9.7%00.0%UnchangedHolders
Q1 20242,650,150$75.2M5.9%+1,000,000+60.6%AddedHolders
Q4 20231,650,150$21.9M2.4%00.0%UnchangedHolders
Q3 20231,650,150$14.8M2.2%00.0%UnchangedHolders
Q2 20231,650,150$18.6M3.0%00.0%UnchangedHolders
Q1 20231,650,150$19.0M3.7%+1,650,150NewHolders